A carregar...
Retreatment with obinutuzumab: An addition to the therapeutic landscape of chronic lymphocytic leukemia
Obinutuzumab is used for the treatment of chronic lymphocytic leukemia. So far there are no data of using this for retreatment in patients who have received it previously. We introduced obinutuzumab for the retreatment in a chronic lymphocytic leukemia patient, who had first achieved partial remissi...
Na minha lista:
| Publicado no: | SAGE Open Med Case Rep |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6350017/ https://ncbi.nlm.nih.gov/pubmed/30728976 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050313X18823917 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|